Concord Wealth Partners - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
4
-97.5%
0.00%
-100.0%
Q1 2022$18,000
-25.0%
1580.0%0.01%
-16.7%
Q4 2021$24,000
+71.4%
158
+58.0%
0.01%0.0%
Q3 2021$14,000
+75.0%
100
+56.2%
0.01%
+200.0%
Q2 2021$8,000640.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders